Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 109

Allogene calls for $100m IPO

The immuno-oncology therapy developer's investors include Pfizer and Gilead Sciences, both of which contributed to a $300m round in January.

Sep 18, 2018

Lucid clears $1bn in funding

The Mitsui-backed luxury electric vehicle developer has agreed a $1bn funding injection from the Saudi Arabian Public Investment Fund.

Sep 18, 2018

Uber approaches $2.5bn Careem acquisition

A purchase of Careem, which is currently being touted at between $2bn and $2.5bn, would allow Didi Chuxing, Rakuten, Daimler, Saudi Telecom and Al Tayyar to exit.

Sep 18, 2018

Unmortgage homes in on seed capital

The MMI-backed Anthemis Exponential Ventures was among the investors in a $14.3m seed round as Unmortgage prepares for a 2019 launch.

Sep 17, 2018

Beekeeper collects $13m

Swiss Post, Samsung and Edenred helped workplace communication platform Beekeper add more series A funding to the $8m it raised last year.

Sep 17, 2018

Treitz tries on AWS role

Amazon Web Services has hired Ewa Treitz from fund manager Black Pearls as a business development manager to work with startups.

Sep 17, 2018

System1 processes $25m

The psychiatric and neurological disease drug developer has secured $25m in a series B round co-led by Pfizer Ventures.

Sep 17, 2018

Q4 quickens pace to raise $38m

OpenText Enterprise Apps Fund returned to back investor relations software provider Q4, two years after co-leading its series B round.

Sep 17, 2018

StockX consumes $44m in series B round

The consumer goods trading platform has closed a round co-led by GV that will fund the expansion of its trading options and authentication centres.

Sep 17, 2018

Samsung helps upload $60m to Datrium

Samsung Catalyst Fund has led a $60m series D round for Datrium, a cloud computing technology developer that has now attracted $170m in funding to date.

Sep 17, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here